Minimal residual disease in multiple myeloma: bringing the bench to the bedside
Minimal residual disease in multiple myeloma: bringing the bench to the bedside
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
Outcomes of patients with multiple myeloma have improved substantially in the past decade
A large proportion of patients achieve a complete response to current therapies
More-sensitive assays for the detection of MRD are required
Standardization and guidelines on the use of MRD testing in clinical trials and in the clinic are...
Alternative Titles
Full title
Minimal residual disease in multiple myeloma: bringing the bench to the bedside
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7712493
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7712493
Other Identifiers
ISSN
1759-4774
E-ISSN
1759-4782
DOI
10.1038/nrclinonc.2014.239
